Selected Summer Publications from Joslin Faculty
At Joslin, our researchers are making incredible discoveries that improve diabetes care and move us closer to a cure. Below are selected academic publications led by Joslin faculty issued in June, July and August.
Endothelial cells induced progenitors into brown fat to reduce atherosclerosis
Circulation Research / Original Research / June 1, 2022
Joslin Authors: Kyoungmin Park, Qian Li, Matthew D. Lynes, Hisashi Yokomizo, Takanori Shinjo, Ronald St-Louis, Qin Li, Jialin Fu, Allen Clermont, Hyunseok Park, I-Hsien Wu, Marc Gregory Yu, Hetal Shah, Yu-Hua Tseng, George L. King
Brown adipose tissue-derived MaR2 contributes to cold-induced resolution of inflammation
Nature Metabolism / Original Research / June 27, 2022
Joslin Authors: Satoru Sugimoto, Shio Kobayashi, Tadataka Tsuji, Chih-Hao Wang, Tian Lian Huang, Joji Kusuyama, Sean D. Kodani, Justin Darcy, Gerson Profeta, Thomas Serwold, Laurie J. Goodyear, Luiz Osório Leiria, Yu-Hua Tseng
A gut microbial peptide and molecular mimicry in the pathogenesis of type 1 diabetes
PNAS / Original Research / July 25, 2022
Joslin Author: C. Ronald Kahn
Neuroblastoma suppressor of tumorigenicity 1 is a circulating protein associated with progression to end-stage kidney disease in diabetes
Science Translational Medicine / Original Research / August 10, 2022
Joslin Authors: Hiroki Kobayashi, Eiichiro Satake, Zaipul I. Md Dom, Kristina O’Neil, Katsuhito Ihara, Bozena Krolewski, Monika A. Niewczas, Alessandro Doria, Andrzej S. Krolewski
Association of predominantly peripheral lesions on ultra-widefield imaging and the risk of diabetic retinopathy worsening over time
JAMA Ophthalmology / Original Research / August 18, 2022
Joslin Authors: Paolo S. Silva, Lloyd Paul Aiello, Jennifer K. Sun
Association of ultra-widefield fluorescein angiography–identified retinal nonperfusion and the risk of diabetic retinopathy worsening over time
JAMA Ophthalmology / Original Research / August 19, 2022
Joslin Authors: Paolo S. Silva, Lloyd Paul Aiello, Jennifer K. Sun
About Joslin Diabetes Center
Joslin Diabetes Center is world-renowned for its deep expertise in diabetes treatment and research. Part of Beth Israel Lahey Health, Joslin is dedicated to finding a cure for diabetes and ensuring that people with diabetes live long, healthy lives. We develop and disseminate innovative patient therapies and scientific discoveries throughout the world. Joslin is affiliated with Harvard Medical School and one of only 18 NIH-designated Diabetes Research Centers in the United States.
